Research Article

Effects of metformin in an experimental chronic unpredictable mild stress model

Volume: 30 Number: 1 January 11, 2026
EN

Effects of metformin in an experimental chronic unpredictable mild stress model

Abstract

Prolonged interaction with challenging life situations is a well-recognised risk factor for depression, anxiety, and cognitive decline, particularly among menopausal women. This research aimed to assess the effects of metformin (MF) on anxiety-like behavioural changes, cognitive impairment, brain neuroplasticity, and apoptosis induced by chronic unpredictable mild stress (CUMS) in menopausal rats. To achieve this, we conducted the open field test (OFT) to measure anxiety- like behaviours and locomotor activity, the elevated plus- maze (EPM) to assess anxiety-like behaviour, and the novel object recognition test (NORT) to evaluate recognition memory. Additionally, we measured the levels of BDNF, SIRT 1, synaptophysin, and caspase-9 by ELISA in the hippocampus, prefrontal cortex (PFC), and amygdala. Our experimental groups were categorised into five groups, with six rats in each group, as follows: Control, ovariectomized (OVX), OVX+CUMS, OVX+MF, and OVX+CUMS+MF. Four weeks after the OVX, the CUMS protocol was implemented, and MF treatment commenced following CUMS and continued for 14 days. Chronic administration of MF improved recognition memory and anxiety levels in rats subjected to CUMS, as assessed by the NORT, OFT, and EPM. MF increased brain-derived neurotrophic factor, synaptophysin, and sirtuin1, key markers of neuroplasticity in specific brain regions. We also found that MF treatment reduced pro-apoptotic caspase-9 levels. Histopathological analysis of the hippocampal DG and prefrontal cortex indicated neurodegenerative changes such as pyknotic nuclei, cytoplasmic sparseness, widespread vacuolization, and perivascular and pericellular oedema in the OVX and OVX+CUMS groups. However, these pathological features were significantly diminished in the MF groups, resulting in better preservation of neuronal integrity, fewer pyknotic cells, and reduced vacuolization. In conclusion, metformin appears to be a beneficial therapeutic agent that enhances neural plasticity, decreases apoptosis, and improves recognition memory and anxiety- like behaviours induced by OVX+CUMS

Keywords

Supporting Institution

This study has been supported by Marmara University Scientific Research Projects Coordination Unit (BABKO) under grant number: 11465.

Project Number

TYL-2024-11465

References

  1. [1] Kuck MJ, Hogervorst E. Stress, depression, and anxiety: psychological complaints across menopausal stages. Front Psychiatry. 2024; 15:1323743. https://doi.org/10.3389/fpsyt.2024.1323743.
  2. [2] Soares CN, Zitek B. Reproductive hormone sensitivity and risk for depression across the female life cycle: a continuum of vulnerability? J Psychiatry Neurosci. 2008; 33(4):331-343.
  3. [3] Azarfarin M, Moradikor N, Salatin S, Sarailoo M, Dadkhah M. Stress-related neurodegenerative diseases: Molecular mechanisms implicated in neurodegeneration and therapeutic strategies. Prog Brain Res. 2025; 291:253-288. https://doi.org/10.1016/bs.pbr.2025.01.011.
  4. [4] Kline SA, Mega MS. Stress-Induced Neurodegeneration: The Potential for Coping as Neuroprotective Therapy. Am J Alzheimers Dis Other Demen. 2020;35:1533317520960873. https://doi.org/10.1177/1533317520960873
  5. [5] Lupien SJ, Juster RP, Raymond C, Marin MF. The effects of chronic stress on the human brain: From neurotoxicity, to vulnerability, to opportunity. Front Neuroendocrinol. 2018; 49:91-105. https://doi.org/10.1016/j.yfrne.2018.02.001.
  6. [6] Bondi CO, Rodriguez G, Gould GG, Frazer A, Morilak DA. Chronic unpredictable stress induces a cognitive deficit and anxiety-like behavior in rats that is prevented by chronic antidepressant drug treatment. Neuropsychopharmacology. 2008; 33(2):320-331. https://doi.org/10.1038/sj.npp.1301410.
  7. [7] Perna G, Alciati A, Sangiorgio E, Caldirola D, Nemeroff CB. Personalized Clinical Approaches to Anxiety Disorders. Adv Exp Med Biol. 2020; 1191:489-521. https://doi.org/10.1007/978-981-32-9705-0_25.
  8. [8] Tekşen Y, Gündüz MK, Berikten D, Özatik FY, Aydın HE. Peganum harmala L. seed extract attenuates anxiety and depression in rats by reducing neuroinflammation and restoring the BDNF/TrkB signaling pathway and monoamines after exposure to chronic unpredictable mild stress. Metab Brain Dis. 2024; 39(8):1523-1541. https://doi.org/10.1007/s11011-024-01416-6.

Details

Primary Language

English

Subjects

Clinical Pharmacology and Therapeutics

Journal Section

Research Article

Publication Date

January 11, 2026

Submission Date

May 3, 2025

Acceptance Date

May 30, 2025

Published in Issue

Year 2026 Volume: 30 Number: 1

APA
Ozsagır, M. H., Polat, E. B., Çilingir Kaya, Ö. T., Aykaç, A., & Özbeyli, D. (2026). Effects of metformin in an experimental chronic unpredictable mild stress model. Journal of Research in Pharmacy, 30(1), 171-185. https://doi.org/10.12991/jrespharm.1690442
AMA
1.Ozsagır MH, Polat EB, Çilingir Kaya ÖT, Aykaç A, Özbeyli D. Effects of metformin in an experimental chronic unpredictable mild stress model. J. Res. Pharm. 2026;30(1):171-185. doi:10.12991/jrespharm.1690442
Chicago
Ozsagır, Mehmet Haktan, Elif Beyzanur Polat, Özlem Tuğçe Çilingir Kaya, Aslı Aykaç, and Dilek Özbeyli. 2026. “Effects of Metformin in an Experimental Chronic Unpredictable Mild Stress Model”. Journal of Research in Pharmacy 30 (1): 171-85. https://doi.org/10.12991/jrespharm.1690442.
EndNote
Ozsagır MH, Polat EB, Çilingir Kaya ÖT, Aykaç A, Özbeyli D (January 1, 2026) Effects of metformin in an experimental chronic unpredictable mild stress model. Journal of Research in Pharmacy 30 1 171–185.
IEEE
[1]M. H. Ozsagır, E. B. Polat, Ö. T. Çilingir Kaya, A. Aykaç, and D. Özbeyli, “Effects of metformin in an experimental chronic unpredictable mild stress model”, J. Res. Pharm., vol. 30, no. 1, pp. 171–185, Jan. 2026, doi: 10.12991/jrespharm.1690442.
ISNAD
Ozsagır, Mehmet Haktan - Polat, Elif Beyzanur - Çilingir Kaya, Özlem Tuğçe - Aykaç, Aslı - Özbeyli, Dilek. “Effects of Metformin in an Experimental Chronic Unpredictable Mild Stress Model”. Journal of Research in Pharmacy 30/1 (January 1, 2026): 171-185. https://doi.org/10.12991/jrespharm.1690442.
JAMA
1.Ozsagır MH, Polat EB, Çilingir Kaya ÖT, Aykaç A, Özbeyli D. Effects of metformin in an experimental chronic unpredictable mild stress model. J. Res. Pharm. 2026;30:171–185.
MLA
Ozsagır, Mehmet Haktan, et al. “Effects of Metformin in an Experimental Chronic Unpredictable Mild Stress Model”. Journal of Research in Pharmacy, vol. 30, no. 1, Jan. 2026, pp. 171-85, doi:10.12991/jrespharm.1690442.
Vancouver
1.Mehmet Haktan Ozsagır, Elif Beyzanur Polat, Özlem Tuğçe Çilingir Kaya, Aslı Aykaç, Dilek Özbeyli. Effects of metformin in an experimental chronic unpredictable mild stress model. J. Res. Pharm. 2026 Jan. 1;30(1):171-85. doi:10.12991/jrespharm.1690442